To help companies and investors navigate the many evolving and emerging laws and regulations across pharmaceuticals, biologics, medical devices, diagnostics, and laboratory testing, our Life Sciences Regulatory & Compliance team has provided an overview of key developments. We update and publish a quarterly tracker detailing these developments. You can read about the Q2 2025 updates here.
The post A Look Ahead in Life Sciences: What We Are Tracking in the Second Quarter of 2025 and Beyond appeared first on Life Sciences Perspectives.